User: Guest  Login
Title:

Galantamine in the treatment of cognitive decline in patients with vascular dementia or Alzheimer's disease with cerebrovascular disease.

Document type:
Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Article
Author(s):
Small, G; Erkinjuntti, T; Kurz, A; Lilienfeld, S
Abstract:
INTRODUCTION: Alzheimer's disease and vascular dementia are the two most common types of dementia, with significant overlap of clinical symptoms and pathology. Previous results from a 6-month, double-blind, placebo-controlled, international, multicentre study of the cholinomimetic galantamine in patients with probable vascular dementia or mixed dementia (Alzheimer's disease with cerebrovascular disease) showed significant cognitive, behavioural and functional benefits in these patients. Furtherm...     »
Journal title abbreviation:
CNS Drugs
Year:
2003
Journal volume:
17
Journal issue:
12
Pages contribution:
905-14
Language:
eng
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/12962529
Print-ISSN:
1172-7047
TUM Institution:
Klinik und Poliklinik für Psychiatrie und Psychotherapie
 BibTeX